Evaluation and Comparison of Choroidal Thickness in Patients with Behçet Disease with versus without Ocular Involvement.
Behçet's Uveitis
Choroidal Thickness
Enhanced Depth Imaging Optical Coherence Tomography (EDI-OCT)
Ocular Behçet
Wide Field Fluorescein Angiography
Behçet's Disease
Journal
Journal of ophthalmic & vision research
ISSN: 2008-2010
Titre abrégé: J Ophthalmic Vis Res
Pays: United Arab Emirates
ID NLM: 101497643
Informations de publication
Date de publication:
Historique:
received:
15
06
2019
accepted:
09
01
2021
entrez:
31
5
2021
pubmed:
1
6
2021
medline:
1
6
2021
Statut:
epublish
Résumé
To assess the subfoveal choroidal thickness (SFCT) in patients with Behçet disease (BD) and compare the SFCT in patients with and without ocular BD (OBD) and between patients with active and quiescent phases of the Behçet's posterior uveitis. This prospective cross-sectional study was conducted on patients with BD ( One hundred and two eyes of 51 patients with BD, aged 29 to 52 years were studied. Of these, 23 patients were male. The mean age Choroidal thickness was significantly increased in BD patients with ocular involvement; therefore, EDI-OCT could be a noninvasive test for evaluation of ocular involvement in patients with BD. The increased SFCT was not an indicative of activity in OBD; however, it could predict possible ocular involvement throughout the disease course.
Identifiants
pubmed: 34055257
doi: 10.18502/jovr.v16i2.9083
pmc: PMC8126733
doi:
Types de publication
Journal Article
Langues
eng
Pagination
195-201Informations de copyright
Copyright © 2021 Hosseini et al.
Déclaration de conflit d'intérêts
The authors have no conflicts of interest to declare.
Références
Autoimmunity. 1992;12(3):201-6
pubmed: 1364205
Medicine (Baltimore). 1951 Dec;30(4):335-55
pubmed: 14890444
Ocul Immunol Inflamm. 2017 Feb;25(1):7-19
pubmed: 27541278
Eur J Ophthalmol. 2002 Sep-Oct;12(5):424-31
pubmed: 12474927
Middle East Afr J Ophthalmol. 2009 Oct;16(4):219-24
pubmed: 20404988
Retina. 2017 Sep;37(9):1678-1691
pubmed: 28002270
J Ophthalmol. 2014;2014:865394
pubmed: 24868459
Br J Ophthalmol. 2014 Nov;98(11):1508-13
pubmed: 24939422
Int Ophthalmol Clin. 2012 Fall;52(4):183-90
pubmed: 22954940
Graefes Arch Clin Exp Ophthalmol. 1989;227(4):340-4
pubmed: 2777102
Ophthalmology. 2013 Sep;120(9):1901-8
pubmed: 23664466
Prog Retin Eye Res. 2008 Jan;27(1):111-36
pubmed: 18035584
Br J Ophthalmol. 2003 Dec;87(12):1466-8
pubmed: 14660454
Best Pract Res Clin Rheumatol. 2018 Apr;32(2):261-270
pubmed: 30527431
Surv Ophthalmol. 1997 Sep-Oct;42(2):157-62
pubmed: 9381369
Retina. 2015 Mar;35(3):525-31
pubmed: 25105317
Graefes Arch Clin Exp Ophthalmol. 2014 Jun;252(6):1001-8
pubmed: 24796770
Retina. 2018 Apr;38(4):828-840
pubmed: 28272284
Int Ophthalmol. 1985 Mar;7(3-4):183-91
pubmed: 3997360
Int Ophthalmol. 2010 Oct;30(5):539-52
pubmed: 18795232
Am J Ophthalmol. 2004 Sep;138(3):373-80
pubmed: 15364218
Invest Ophthalmol Vis Sci. 2013 Sep 05;54(9):6033-9
pubmed: 23900605
Int Ophthalmol. 2019 Oct;39(10):2391-2399
pubmed: 30710254
Ocul Immunol Inflamm. 2013 Dec;21(6):440-5
pubmed: 23895216
Clin Exp Ophthalmol. 2009 Jan;37(1):130-43
pubmed: 19338610
Ocul Immunol Inflamm. 2017 Feb;25(1):20-28
pubmed: 27230121